Gene expression profiling predicts clinical outcome of prostate cancer - Test2 - elhamkhani - TriplyDB

Gene expression profiling predicts clinical outcome of prostate cancer

Gene expression profiling predicts clinical outcome of prostate cancer

http://www.wikidata.org/entity/Q24594253

about

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer Evaluation of protein biomarkers of prostate cancer aggressiveness Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer Mammalian Krüppel-like factors in health and diseases The role of SPINK1 in ETS rearrangement-negative prostate cancers An immunologic portrait of cancer A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.Identification of targetable FGFR gene fusions in diverse cancers.Role of the TMPRSS2-ERG gene fusion in prostate cancer Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer Tumor suppressor and hepatocellular carcinoma An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3 EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.HNF1B and endometrial cancer risk: results from the PAGE study.Data Requirements for Model-Based Cancer Prognosis Prediction Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.Integrative molecular concept modeling of prostate cancer progression.A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy Statistical issues and analyses of in vivo and in vitro genomic data in order to identify clinically relevant profiles.Prostate cancer-associated gene expression alterations determined from needle biopsies.Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.Molecular sampling of prostate cancer: a dilemma for predicting disease progression.JISTIC: identification of significant targets in cancer.Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer Genomic profiling of tumor initiating prostatospheres.COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.NF-κB gene signature predicts prostate cancer progression.Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer

P2860

Q21202034-4BE90796-4337-44F5-8C0C-53C7E8227A6F Q21261257-4DAD80BF-8EDB-4DB6-966C-49A759DEC380 Q24528253-BA077F62-93B1-47E1-BAD2-A67469E6A461 Q24612560-68B5A21C-AF0A-49BC-852B-DE41070C927D Q24647020-2A8F0F18-0C03-4EF6-8298-9C39A7092F82 Q27028000-B1A1FD33-2A01-4260-8810-C4E7A2E1154F Q27303204-8F68BD4E-EDDF-427C-B6A5-988C6DBC336D Q27851411-38B28939-3274-4A81-8111-0F1212530367 Q27852147-CE02CBA2-6EAD-4979-B40B-BF8493B1D78D Q28269156-4CCEBB05-AB45-41D8-9F30-CDDF536E174F Q28292092-9429F9F5-3BFC-48F4-A3B1-6076A4483F82 Q28308288-E1F0E941-A7D8-4052-B6F4-6501911BF49F Q28389231-FBB34CD0-1C92-4798-81CD-1BACB3B71F82 Q28484126-C056CC61-1E17-43BD-8CF1-9EB5B8275535 Q28534277-27F04D50-1623-4DCE-8713-DA835D3DC2DF Q28731283-C29BEB22-36DD-49A6-BECB-91BA7AA971FD Q28771723-3229469D-3922-49B1-8356-FD7825EF15AC Q30538848-2D76BEF7-EC6F-4B0E-AEB9-EFF1F4D3B732 Q31047674-E5AFBD54-385C-4720-A822-E17215960F9A Q31087381-DDBF7EBE-81CB-48FC-B4C6-8AEF38AEE534 Q31130674-EB850D7A-79F6-4860-892F-943BD51E67B3 Q33266777-A4791293-2937-4605-87FE-88D2DF5977DE Q33289245-3D33ED67-37E0-4520-8F4E-D0E087D95181 Q33314433-2AA1C8F0-7591-4F52-9308-2471377E58B4 Q33324395-68B37BC7-2F37-4397-9B9E-5C835BA76E70 Q33361134-00752AC7-DC11-4982-8093-F1307C8ACAEA Q33375063-69C607BC-A3DB-44FD-B538-7F305173215F Q33392732-56439E58-0942-4355-A1DC-A3A64AAEBE19 Q33430210-2189446F-1336-4129-B05E-DB75BF1509AF Q33490254-2ADD50E5-161A-4DC5-A9A2-7EB6FB80328B Q33519740-2D312818-2DA9-4318-8D84-D84EFCF068EC Q33541296-9ECC3F24-02D2-4D19-B01D-985D6A68E6FD Q33557528-EE3A1F1D-1A66-41D2-8FB4-641BB2ECF622 Q33571906-28A42382-1833-4211-A5F7-1BBD168D25BA Q33586722-6F43C6E1-5F87-43D0-AC5A-DA404C486155 Q33617181-08948225-928C-44B9-9E54-CDE0115B8C03 Q33624908-0CC89219-E268-4891-B186-3DCA22D0B164 Q33658285-36E0831E-3B6A-4043-AE66-85BFAF94B0D4 Q33682993-2B9B246C-A4BE-4E94-AE00-5F70799625A4 Q33698635-0DFD368A-DA92-447D-8605-60E83F289AEB

P2860

Gene expression profiling predicts clinical outcome of prostate cancer

http://www.wikidata.org/entity/Q24594253

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Gene expression profiling predicts clinical outcome of prostate cancer

@ast

Gene expression profiling predicts clinical outcome of prostate cancer

@en

Gene expression profiling predicts clinical outcome of prostate cancer

@nl

type

label

Gene expression profiling predicts clinical outcome of prostate cancer

@ast

Gene expression profiling predicts clinical outcome of prostate cancer

@en

Gene expression profiling predicts clinical outcome of prostate cancer

@nl

prefLabel

Gene expression profiling predicts clinical outcome of prostate cancer

@ast

Gene expression profiling predicts clinical outcome of prostate cancer

@en

Gene expression profiling predicts clinical outcome of prostate cancer

@nl

P1433

Q24594253-B0E33A1A-9CF1-4029-8726-300764AE1AF4

P1476

Q24594253-95B80868-B3B7-4E3F-B78F-F95DCEDC4A96

P2093

Q24594253-619F9AC0-E8DE-4701-8BD0-984B91BBC259

Q24594253-73C182A8-DB48-4E53-A768-7889D5D3EA1F

Q24594253-AB61F197-BB6D-42B5-8C75-42B1DB90C514

Q24594253-C04A9F45-C195-44E2-A31B-EFA60674B471

Q24594253-CF4032CD-29DE-4BD4-A0AB-E8F36544E222

P2860

Q24594253-0F0F3896-5FD8-48CF-8F6D-61E6CA70DC71

Q24594253-1EFC630D-98FC-4EC1-83E3-C6832C45F3DF

Q24594253-231A9C21-3BA1-4FDB-8D24-635B84450AA9

Q24594253-3B35DD0B-2976-4DF3-AA29-6A0606966E89

Q24594253-3E1A6621-90C4-4840-B082-4420A48473DF

Q24594253-57C8372A-EF75-459F-9876-F03B8CFB2940

Q24594253-5CB8B0BD-BEC5-47B8-878C-64EF30D76DFE

Q24594253-63822FD7-7A32-44AC-A2B2-596B1324FFA5

Q24594253-6783D3DC-A7A6-4B7C-99F2-59C29BB07315

Q24594253-732DAE21-8600-460C-98B1-F453D04B40B0

P304

Q24594253-A20A7BAB-ACA1-4748-9BB7-BE4F864B0319

P31

Q24594253-34A56ACB-93D2-47AD-926B-2045470EB802

P3181

Q24594253-3B8243F8-F071-4ABB-879F-AE73B12A8ACD

P356

Q24594253-50CE6CF4-2AD9-41D6-8413-FB8CC0252729

P407

Q24594253-C5E7CA11-A954-4CDD-8228-70D6B94E55A2

P433

Q24594253-394B51A0-038E-4368-A823-12DB95AAAB37

P478

Q24594253-B00B0DD7-D3D7-42B9-A093-1823A0B32A78

P577

Q24594253-3B3E829A-9316-4420-809D-011F38632ED8

P698

Q24594253-A22D14E1-147C-4774-97E1-D02EEA756194

P932

Q24594253-B8A20034-B0F2-4C1B-9074-374433445C9F

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Gene expression profiling predicts clinical outcome of prostate cancer

@en

P2093

Andrew J Stephenson

http://www.w3.org/2001/XMLSchema#string

Anna B Glinskii

http://www.w3.org/2001/XMLSchema#string

Gennadi V Glinsky

http://www.w3.org/2001/XMLSchema#string

Robert M Hoffman

http://www.w3.org/2001/XMLSchema#string

William L Gerald

http://www.w3.org/2001/XMLSchema#string

P2860

Deletion, mutation, and loss of expression of KLF6 in human prostate cancer

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Cancer statistics, 2001

KLF6, a candidate tumor suppressor gene mutated in prostate cancer

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis

A role for Wnt signalling in self-renewal of haematopoietic stem cells

A molecular signature of metastasis in primary solid tumors

The polycomb group protein EZH2 is involved in progression of prostate cancer

Wnt proteins are lipid-modified and can act as stem cell growth factors

P304

913-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

332168

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI20032

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15067324

http://www.w3.org/2001/XMLSchema#string

P932

362118

http://www.w3.org/2001/XMLSchema#string